Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 618

1.

Epstein-Barr virus polymerase chain reaction-negative stage IV post-transplant lymphoproliferative disorder in a heart transplant patient treated with rituximab.

Garceau P, Couture C, Cantin B, Bernier V, Sénéchal M.

J Heart Lung Transplant. 2008 Aug;27(8):928-31. doi: 10.1016/j.healun.2008.05.020. Epub 2008 Jul 3.

PMID:
18656811
[PubMed - indexed for MEDLINE]
2.

Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.

Omar H, Hägglund H, Gustafsson-Jernberg A, LeBlanc K, Mattsson J, Remberger M, Ringdén O, Sparrelid E, Sundin M, Winiarski J, Yun Z, Ljungman P.

Transpl Infect Dis. 2009 Oct;11(5):393-9. doi: 10.1111/j.1399-3062.2009.00410.x. Epub 2009 May 26.

PMID:
19497070
[PubMed - indexed for MEDLINE]
3.

Treatment of post-transplant lymphoproliferative disorder with monoclonal CD20 antibody (rituximab) after heart transplantation.

Zilz ND, Olson LJ, McGregor CG.

J Heart Lung Transplant. 2001 Jul;20(7):770-2.

PMID:
11448808
[PubMed - indexed for MEDLINE]
4.
5.
6.

Anti-CD20 monoclonal antibody treatment of Epstein-Barr virus-induced intrahepatic lymphoproliferative disorder following liver transplantation.

Yedibela S, Reck T, Niedobitek G, Gramatzki M, Repp R, Hohenberger W, Ott R.

Transpl Int. 2003 Mar;16(3):197-201. Epub 2003 Feb 12.

PMID:
12664216
[PubMed - indexed for MEDLINE]
7.

Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication.

Verschuuren EA, Stevens SJ, van Imhoff GW, Middeldorp JM, de Boer C, Koëter G, The TH, van Der Bij W.

Transplantation. 2002 Jan 15;73(1):100-4.

PMID:
11792987
[PubMed - indexed for MEDLINE]
8.

Lymphoproliferative disorder of the airway of an adolescent without immunodeficiency.

Boesch RP, Daines M, Kaul A, Cotton R, Amin R.

Int J Pediatr Otorhinolaryngol. 2005 Nov;69(11):1591-4. Epub 2005 Jun 15.

PMID:
15963576
[PubMed - indexed for MEDLINE]
9.

Limitations of EBV-PCR monitoring to detect EBV associated post-transplant lymphoproliferative disorder.

Axelrod DA, Holmes R, Thomas SE, Magee JC.

Pediatr Transplant. 2003 Jun;7(3):223-7.

PMID:
12756048
[PubMed - indexed for MEDLINE]
10.

Use of EBV PCR for the diagnosis and monitoring of post-transplant lymphoproliferative disorder in adult solid organ transplant patients.

Tsai DE, Nearey M, Hardy CL, Tomaszewski JE, Kotloff RM, Grossman RA, Olthoff KM, Stadtmauer EA, Porter DL, Schuster SJ, Luger SM, Hodinka RL.

Am J Transplant. 2002 Nov;2(10):946-54.

PMID:
12482147
[PubMed - indexed for MEDLINE]
Free Article
11.

Use of cytokine polymorphisms and Epstein-Barr virus viral load to predict development of post-transplant lymphoproliferative disorder in paediatric liver transplant recipients.

Lee TC, Savoldo B, Barshes NR, Rooney CM, Heslop HE, Gee AP, Caldwell Y, Scott JD, Goss JA.

Clin Transplant. 2006 May-Jun;20(3):389-93.

PMID:
16824159
[PubMed - indexed for MEDLINE]
12.

Successful treatment with rituximab of lymphoproliferative disorder in a child after cardiac transplantation.

Herman J, Vandenberghe P, van den Heuvel I, Van Cleemput J, Winnepenninckx V, Van Damme-Lombaerts R.

J Heart Lung Transplant. 2002 Dec;21(12):1304-9.

PMID:
12490276
[PubMed - indexed for MEDLINE]
13.

Acute cellular rejection and Epstein-Barr virus-related post-transplant lymphoproliferative disorder in a pediatric lung transplant with low viral load.

Calabrese F, Loy M, Lunardi F, Marino D, Aversa SM, Rea F.

Transpl Infect Dis. 2010 Aug 1;12(4):342-6. doi: 10.1111/j.1399-3062.2009.00487.x. Epub 2009 Dec 20.

PMID:
20030794
[PubMed - indexed for MEDLINE]
14.

Humanized anti-CD20 monoclonal antibody (Rituximab) treatment for post-transplant lymphoproliferative disorder.

Ganne V, Siddiqi N, Kamaplath B, Chang CC, Cohen EP, Bresnahan BA, Hariharan S.

Clin Transplant. 2003 Oct;17(5):417-22.

PMID:
14703923
[PubMed - indexed for MEDLINE]
15.

Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Styczynski J, Gil L, Tridello G, Ljungman P, Donnelly JP, van der Velden W, Omar H, Martino R, Halkes C, Faraci M, Theunissen K, Kalwak K, Hubacek P, Sica S, Nozzoli C, Fagioli F, Matthes S, Diaz MA, Migliavacca M, Balduzzi A, Tomaszewska A, Camara Rde L, van Biezen A, Hoek J, Iacobelli S, Einsele H, Cesaro S; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

Clin Infect Dis. 2013 Sep;57(6):794-802. doi: 10.1093/cid/cit391. Epub 2013 Jun 13.

PMID:
23771985
[PubMed - indexed for MEDLINE]
Free Article
16.

Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation.

Ahmad I, Cau NV, Kwan J, Maaroufi Y, Meuleman N, Aoun M, Lewalle P, Martiat P, Crokaert F, Bron D.

Transplantation. 2009 Apr 27;87(8):1240-5. doi: 10.1097/TP.0b013e31819f1c49.

PMID:
19384173
[PubMed - indexed for MEDLINE]
17.

Anti-CD20 monoclonal antibody (Rituximab) treatment for Epstein-Barr virus-associated, B-cell lymphoproliferative disease in pediatric liver transplant recipients.

Serinet MO, Jacquemin E, Habes D, Debray D, Fabre M, Bernard O.

J Pediatr Gastroenterol Nutr. 2002 Apr;34(4):389-93.

PMID:
11930095
[PubMed - indexed for MEDLINE]
18.

Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.

Styczynski J, Einsele H, Gil L, Ljungman P.

Transpl Infect Dis. 2009 Oct;11(5):383-92. doi: 10.1111/j.1399-3062.2009.00411.x. Epub 2009 Jun 23. Review.

PMID:
19558376
[PubMed - indexed for MEDLINE]
19.

Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.

Weinstock DM, Ambrossi GG, Brennan C, Kiehn TE, Jakubowski A.

Bone Marrow Transplant. 2006 Mar;37(6):539-46. Review.

PMID:
16462755
[PubMed - indexed for MEDLINE]
20.

Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.

Schubert S, Renner C, Hammer M, Abdul-Khaliq H, Lehmkuhl HB, Berger F, Hetzer R, Reinke P.

J Heart Lung Transplant. 2008 Jan;27(1):100-5. doi: 10.1016/j.healun.2007.09.027.

PMID:
18187094
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk